3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Melanoma
6
Lung Neoplasms
6
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Glioblastoma
3
Breast Neoplasms
3
Brain Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Interventions
Temozolomide
66
Radiotherapy
34
Carboplatin
22
Carmustine
21
Bevacizumab
21
Irinotecan
18
Filgrastim
18
Surgical Procedures, Operative
14
Vincristine
11
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Radiation
10
O(6)-benzylguanine
10
Magnetic Resonance Spectroscopy
9
Lomustine
9
Procarbazine
8
Erlotinib Hydrochloride
8
sargramostim
7
IL13-PE38
7
Everolimus
7
Cyclophosphamide
7
Chemotherapy, Adjuvant
7
Thiotepa
6
Radiotherapy, Intensity-Modulated
6
Imatinib Mesylate
6
Granulocyte Colony-Stimulating Factor
6
Drug Therapy
6
Cisplatin
6
temsirolimus
5
antineoplaston AS 2-1
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Astrocytoma
×
Immunotherapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled